Vistusertib, 98%, a novel mTOR inhibitor - 100MG 100mg
Prod No.CASMDLUnitsPriceQuantity
VL263791-100MG 1009298-59-2     
 
 
Vistusertib, 98%, a novel mTOR inhibitor - 25MG 25mg
Prod No.CASMDLUnitsPriceQuantity
VL263791-25MG 1009298-59-2     
 
 
Vistusertib, 98%, a novel mTOR inhibitor - 5MG 5mg
Prod No.CASMDLUnitsPriceQuantity
VL263791-5MG 1009298-59-2     
 
 
3-(2,4-Bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-N-methylbenzamide
Prod No.CASMDLUnitsPriceQuantity
VL431103 1009298-59-2     
 
 
3-(2,4-Bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-N-methylbenzamide 1g
Prod No.CASMDLUnitsPriceQuantity
VL431103-1g 1009298-59-2  
  VL431103-1g  3-(2,4-Bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-N-methylbenzamide 1g 1.462,00 
 
 
3-(2,4-Bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-N-methylbenzamide 250mg
Prod No.CASMDLUnitsPriceQuantity
VL431103-250mg 1009298-59-2  
  VL431103-250mg  3-(2,4-Bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-N-methylbenzamide 250mg 595,00